Pharma Diagnostics - May 7, 2014
Dako launches ready-to-use antibodies for cancer diagnosis
The company adds two new antibodies to the Dako portfolio of reagents, instruments and software. The two antibodies are Anti-CK 8/18 and Anti-TdT. Anti-CK 8/18 is the first rabbit monoclonal antibody cocktail for cytokeratin 8/18 (CK 8/18) available from a major pathology provider. It is used by pathologists to stain CK 8/18 in tissue samples and […]
Drug Development Pharma - February 27, 2013
Dako teams up with Pfizer
Dako announced in mid-February that the company has entered into a collaboration agreement with Pfizer in the field of companion diagnostics. The agreement constitutes a legal framework for various collaboration projects between the two companies, covering research, development and commercialization as well as advisory services. “We are extremely excited to partner with Pfizer, a company […]